TTK Healthcare Limited has scheduled a meeting of its Board of Directors for Thursday, August 6, 2026. The primary agenda item for this meeting is to consider and approve the Unaudited Financial Results of the Company for the First Quarter ended June 30, 2026 (Q1 FY27).
The disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Additionally, the company confirms that the Trading Window for dealing in the company's shares by Designated Persons and their immediate relatives remains closed from July 1, 2026 to August 8, 2026 (both days inclusive). This closure was previously communicated via letter No. TTKH:SEC:SL:095:26 dated June 22, 2026, and is implemented in compliance with the amended SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading.
All Designated Persons of the Company and their immediate relatives have been formally instructed not to trade in the Company's shares during this specified closure period.